The Corning® Ascent Fixed Bed Reactor (FBR) System: Designed for high yield, scalable viral vector production & other applications for cell & gene therapies.

Cell & Gene Therapy Insights 2021; 7(3), 355


Published: 29 April 2021
Zara Melkoumian

Watch the video or read the poster to learn how to:

  • Intensify adherent cell-based bioproduction
  • Achieve uniformity and high yield
  • Harvest cells efficiently

About the speaker

Zara Melkoumian holds a PhD in Pharmacology and Toxicology and has 15 years of industry experience in bringing innovative cell culture products and technologies to market. Prior to joining Corning, Zara was a post-doctoral fellow at Cornell University where she studied the mechanism of action of a novel tumor suppressor gene in human breast cancer cells.